We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Life Technologies to Collaborate with Boston Children's Hospital
News

Life Technologies to Collaborate with Boston Children's Hospital

Life Technologies to Collaborate with Boston Children's Hospital
News

Life Technologies to Collaborate with Boston Children's Hospital

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Life Technologies to Collaborate with Boston Children's Hospital"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Life Technologies Corporation and Boston Children's Hospital has announced a research and development collaboration to develop an end-to-end genetic sequencing lab workflow based on Life Technologies' Ion Proton™ Sequencer.

The parties plan to collaborate and develop an optimized laboratory infrastructure and lab protocols for an advanced sequencing facility to be built at Boston Children's in compliance with CLIA and CAP certification standards.

The collaboration expects to benefit from Life Technologies' leading expertise in DNA sequencing technology and bioinformatics, and Boston Children's clinical research, genomics and informatics expertise.

Dr. David Margulies, director of The Gene Partnership Program at Boston Children's Hospital said: "This collaboration is an important first step toward providing informed, personalized care for patients whose conditions are difficult to treat. The development of an optimized laboratory infrastructure will support our mission of providing the highest quality, innovative and cost effective care to our patients."

Dr. Paul Billings, Chief Medical Officer at Life Technologies adds: "We are excited at the prospect of collaborating with the world-renowned experts in pediatric genetic disease at Boston Children's to develop and demonstrate best practices for using our proprietary Ion Torrent sequencing platform. Partnerships like these are essential to our Medical Sciences strategy as we seek to assist researchers in discovering improved diagnostics and treatments for genetic conditions."

Advertisement